Hunan Jingfeng Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 553.83 million compared to CNY 611.82 million a year ago. Revenue was CNY 553.83 million compared to CNY 611.82 million a year ago.

Net loss was CNY 35.47 million compared to CNY 29.46 million a year ago. Basic loss per share from continuing operations was CNY 0.0403 compared to CNY 0.0335 a year ago. Diluted loss per share from continuing operations was CNY 0.0403 compared to CNY 0.0335 a year ago.